| DE3018900 | ||||
| DE4106279 | ||||
| DE4140440 | ||||
| WO/1990/009096 | METHOD OF SCREENING AND CLASSIFYING COMPOUNDS | |||
| WO/2000/034438 | METHOD FOR CONSTRUCTING LIBRARIES OF PHENOTYPIC PROFILES |
The present invention relates to a method of investigating the suitability of a material as a medicament for mammals, particularly humans. The invention further relates to a kit with which such a method can be put into practice.
The development of new medicaments takes a total of 10 to 12 years on average. A large part of this time is taken up initially in targeting a material which may be suitable for a specific indication. The number of initially screened substances frequently runs into hundreds of thousands. There is therefore a particular need for a simple and rapid test method by which the substances to be examined can basically be categorized as suitable or unsuitable, but no methods are currently known which are capable of predicting a possible efficacy in humans (or other mammals) with a high degree of reliability. Animal models are of course available for this purpose, but they are either unreliable and/or very expensive in terms of their predictive value. Moreover, conventional animal models are increasingly being generally rejected because they cause the animals (for example dogs and monkeys) to suffer. On the other hand, animal models are normally required to have a great similarity to the human organism so as to guarantee some likelihood that the knowledge gained from the animal experiments will be applicable to humans.
There is a particular need for an animal model which has a high predictive value and which can either replace conventional animal models or at least reduce the scale of experiments on higher organisms (such as mammals). This need is particularly relevant in the search for drugs which influence the human perception of pain, e.g. analgesics and sedatives.
The present invention goes back to the discovery that nematodes (threadworms) exhibit a retraction reflex to a local thermal stimulus and that this reflex can be influenced by active substances that affect the human perception of pain. The present invention is based on the knowledge that certain threadworms react in a defined way to locally applied thermal stimuli and that the reflex to this stimulus allows a prediction to be made as regards the effect of a particular material on the sensation of pain in humans (including mammals).
The invention consequently consists of a method of investigating the suitability of a material as a medicament using at least one nematode which has been exposed to the test material, and exposing this nematode to a local thermal stimulus, preferably outside the temperature range 13-26° C. As a result of this stimulus, the nematode exhibits a reflex which can deviate from normal reflex behaviour (normal behaviour) depending on the material used. The thermal stimulus is preferably limited to an area of 10-100 μm
As a rule, to establish suitability or non-suitability, it will suffice qualitatively to record the deviation from previously observed normal behaviour. As the normal behaviour is very distinctive and significant (cf. details below), a deviation will be easy to observe. Normally, it will be possible to examine relatively large populations of nematodes and express a qualitative deviation substantially as a percentage, namely as a percentage of animals which no longer exhibit a particular behaviour after they have been exposed to the material and the thermal stimulus has been applied. However, a particular suitability can also manifest itself as an intensification of the reflex behaviour, especially in the case of algesics. More recently, it has also become possible to use mutants of the nematodes whose reflex behaviour towards the thermal stimulus is not so distinctive and which then exhibit an intensified reflex behaviour after the administration of an algesiogenic substance.
However, the use of the method according to the invention is not restricted to a medicament that influences pain. An effect on the sensation of pain in a typical human signifies nothing other than the fact that particular receptors are responding to a particular compound. However, receptors which cause specific effects often have certain similarities to one another; thus, for example, pain-relieving substances also have particular pharmacological effects in other ranges of indications. Such ranges of indications pertain to anti-inflammatory, antipyretic, sedative, muscle-relaxing and similar effects, inter alia. In the context of the present invention, pain is understood as meaning any type of pain, for example muscular pain or headache/migraine.
This behaviour has been studied in greater detail on nematodes of the genus Caenorhabditis and especially on
It has now been established, surprisingly, that nematodes that have been exposed to particular chemical substances with a pharmacological action in humans exhibit deviations from the normal behaviour described above. The nematodes can be exposed to the test materials in a very wide variety of ways. For example, it is possible to cultivate the animals in Petri dishes with an agar containing the substances of interest. Another possibility, however, is simply to bathe the animals in the test materials. This variant is not only particularly simple but also makes it possible to standardize the concentrations more easily. A study is carried out on well-fed populations of animals which are then incubated with different solutions of the materials in different concentrations. The inventors' experiments have now shown that substances which cause pain as well as those which alleviate pain have a marked effect on the reflex behaviour of the nematode. Thus the reflex behaviour can be influenced on the one hand by a substance which causes hyperalgesia, such as capsaicin, and on the other hand by an effective and specific capsaicin inhibitor, i.e. capzazepine. This observation, namely the modification of reflex behaviour with agonist/antagonist pairs recognized by mammals, makes it possible to draw conclusions about the possible efficacy of a material which is to be examined for its suitability as a medicament.
The FIGURE diagrammatically shows a worm (
The inventors' experiments have thus shown that the use of
I) Rapid reflexive retraction by at least one whole body length and subsequent orientation of the head in another direction.
II) Rapid reflexive retraction, but without backward motion.
III) Slow retraction.
It was observed that normally at least 80% of the animals exhibited a behaviour as in I).
To standardize the method according to the invention, it is advisable to use a laser because this enables a constant thermal stimulus to be applied to the nematodes in a reproducible manner. As the laser beam also causes no permanent damage to the nematodes, the method according to the invention can be carried out repeatedly.
The invention is illustrated in the following Examples.
The well-fed test animals (
These Examples show that the reflex of interest here can be intensified by substances which have a hyperalgesic effect in humans. A reverse (i.e. attenuated) reflex behaviour is observed for substances capable of relieving pain.